| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.16▲ | 4.19▼ | 4.19▼ | 4.02▲ | 3.96▲ |
| MA10 | 4.17▲ | 4.19▼ | 4.13▲ | 3.79▲ | 4.50▼ |
| MA20 | 4.19▼ | 4.10▲ | 4.12▲ | 3.90▲ | 4.11▲ |
| MA50 | 4.18▼ | 4.07▲ | 3.88▲ | 4.47▼ | 3.87▲ |
| MA100 | 4.13▲ | 3.85▲ | 3.80▲ | 4.11▲ | 2.55▲ |
| MA200 | 4.11▲ | 3.79▲ | 4.12▲ | 4.23▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | 0.004▲ | 0.001▲ | 0.080▲ | -0.095▼ |
| RSI | 47.686▼ | 56.618▲ | 59.562▲ | 52.625▲ | 50.657▲ |
| STOCH | 36.845 | 70.053 | 89.403▲ | 70.983 | 18.051▼ |
| WILL %R | -47.368 | -28.000 | -15.730▲ | -12.844▲ | -75.260▼ |
| CCI | -21.392 | 9.085 | 59.620 | 97.684 | -35.930 |
|
Thursday, November 05, 2026 04:00 AM
Topline three-month data from Cohort 2 expected in the first quarter of 2027, with potential pivotal Phase 3 trial dosing anticipated in the second half of 2027RESEARCH TRIANGLE PARK, N.C., Nov. 05, ...
|
|
Monday, November 02, 2026 11:00 PM
RESEARCH TRIANGLE PARK, N.C., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene ...
|
|
Monday, November 02, 2026 01:39 PM
RESEARCH TRIANGLE PARK, N.C., Nov. 02, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/11/26 | 4.02 | 4.24 | 4.01 | 4.18 | 784,700 |
| 05/11/26 | 4.26 | 4.26 | 3.79 | 4.005 | 1,472,977 |
| 04/11/26 | 4.05 | 4.32 | 3.98 | 4.27 | 1,162,109 |
| 03/11/26 | 3.74 | 3.99 | 3.74 | 3.93 | 1,129,726 |
| 02/11/26 | 3.67 | 3.78 | 3.61 | 3.70 | 876,632 |
| 30/10/26 | 3.58 | 3.69 | 3.42 | 3.67 | 1,019,494 |
| 29/10/26 | 3.68 | 3.82 | 3.60 | 3.65 | 708,133 |
| 28/10/26 | 3.44 | 3.69 | 3.40 | 3.68 | 1,033,420 |
| 27/10/26 | 3.32 | 3.53 | 3.28 | 3.46 | 1,303,301 |
| 26/10/26 | 3.49 | 3.50 | 3.23 | 3.32 | 1,520,145 |
|
|
||||
|
|
||||
|
|